Effect of RIF1 on response of non-small-cell lung cancer patients to platinum-based chemotherapy by regulating MYC signaling pathway

Platinum-based chemotherapy is used as first-line therapy for advanced non-small-cell lung cancer (NSCLC). However, there is no effective indicator to predict whether the patient would be chemo-resistant or sensitive to the therapy. In addition, it is urgent to elucidate the mechanisms of cisplatin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mei, Ying, Liu, Yong-Bin, Hu, Dong-Li, Zhou, Hong-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231216/
https://www.ncbi.nlm.nih.gov/pubmed/30443189
http://dx.doi.org/10.7150/ijbs.27710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231216/
https://www.ncbi.nlm.nih.gov/pubmed/30443189
http://dx.doi.org/10.7150/ijbs.27710

Ejemplares similares